A Dose of Digital: Can Pharma Make DTx a Healthy Business?

Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.

As pharmaceutical companies recognise the potential of DTx to improve patient outcomes, differentiate products, and generate real-world treatment data, they are increasingly seeking to incorporate these digital solutions into their business strategies. 

At the same time, however, the rapid growth of the DTx sector has outpaced the ability of healthcare systems to adapt, leading to regulatory uncertainty and slow adoption rates. In this article, we explore the complex landscape of digital therapeutics and the challenges faced by DTx companies in gaining widespread adoption; we conclude by presenting Ipsos' 5-stage framework for developing a resilient and scalable DTx business. 

Download ‘A Dose Of Digital’

Access more Ipsos Healthcare thought leadership here.

Download

Related news

  • NASPL Possible NW
    Consumer Behavior Event

    NASPL Possible NW

    Join Ipsos as we unveil how lotteries are using mystery shopping to unlock revenue hiding in plain sight, with high-performing retailers generating significantly more revenue per square foot through specific, measurable behaviours that any retailer can replicate.
  • [WEBINAR] 2025 KEYS: The Year in Review
    Consumers Events replay

    [WEBINAR] 2025 KEYS: The Year in Review

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • Coffee Association of Canada Conference
    Consumers Event

    Coffee Association of Canada Conference

    We’re excited to announce that Ipsos will be speaking at the Coffee Association of Canada’s Annual Conference on November 5 at Angus Glen Golf Club!